What's New

Trastuzumab-dkst (Ogivri)

Trastuzumab-dkst (Ogivri) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancers. 


OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

Living Life Conference
by OncoLink Team
Jan 12, 2018

Emotions: A Side Effect of Cancer
by Karen Arnold-Korzeniowski, BSN, RN
Jan 12, 2018

View all Blogs

Ringing in the New Year

The New Year is a time to reflect on the past year and look toward the upcoming year. This often inspires people to commit to working towards a healthier lifestyle. Learn about 6 resolutions to reduce cancer risk or starting an exercise regimen. Bob celebrates the New Year with his wishes for people with cancer.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.